<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20221220056884N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-04-28</date_registration>
      <primary_sponsor>Kerman University of Medical Sciences</primary_sponsor>
      <public_title>A comparative study of abdominal and field massage on physiological indicators, weight gain, and digestive function of preterm infants</public_title>
      <acronym></acronym>
      <scientific_title>A comparative study of abdominal and field massage on physiological indicators, weight gain, and digestive function of preterm infants admitted to neonatal intensive care units: A randomized controlled clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-02-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>90</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/67702</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Premature babies in the NICU department who have the conditions to enter the study, using the random block method with the size of blocks of 3 and 9, including (abdominal massage group, field massage and control group) with a 1:1:1 allocation ratio in one of the groups Intervention and control will be placed. Allocation sequence will be determined using the computer program www.Random.org by a person not involved in the selection of the samples, Blinding description: The evaluation of the outcome will be made by someone who is blinded to the groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Preterm newborn.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: The masseur in the intervention group gives her baby abdominal massage for 15 minutes at a certain time (9:00 a.m. and 9:00 p.m.) on five consecutive days (as trained). Intervention 2: Intervention group 2: The masseur gives her neonetals a field massage for 15 minutes at a certain time (9:00 am and 9:00 pm) on five consecutive days (as trained).Field massage is such that each massage will consist of 3 phases of 5 minutes and a total of 15 minutes, in the first and third phase, the baby will be placed on the stomach and the massage will be performed as follows: 1) from the top of the head to the neck and vice versa, 2) from the neck to the shoulders and vice versa, 3) from the upper back to the waist and vice versa, 4) from the shoulder to the hand and then in the reverse direction in both hands, 5) from the thigh to the ankle leg and then in the reverse direction on both legs. In each of the mentioned areas, 12 movements of 5 seconds will be performed. In the second phase, the baby will be in the vault position and the passive movements of flexion and extension of the arms and legs separately and both legs together will be performed in 5 stages of one minute, each stage will include 6 movements of 10 seconds. Takes. Intervention 3: Control group: Newborns in the control group will receive the routine NICU care.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is There is still no plan to develop a program for sharing the data. According to the above sampling data time, the study will be completed by that time.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Golnoush Motamedi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kerman University of Medical Sciences, Pardizeh, Haft Bagh</address>
        <city>Kerman</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7616913555</zip>
        <telephone>+98 34 3132 5207</telephone>
        <email>golnoush.motamedi@gmail.com</email>
        <affiliation>Kerman University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Sedigheh Khodabande Shahraki</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing and Midwifery, Kerman University of Medical Sciences, Haft-bagh Highway, Kerman, Iran</address>
        <city>Kerman</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7616913555</zip>
        <telephone>+98 34 3132 5207</telephone>
        <email>mitra.khodabandeh@yahoo.com</email>
        <affiliation>Kerman University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>The baby being in their first 48 hours after birth
Feeding through a nasogastric tube - French 6 or 8
5th-minute Apgar being 7 or higher
Gestational age between 30 to 34 weeks
Absence of severe respiratory distress
Weight between 1000 and 1750 grams
No need for ventilation
Absence of mother's addiction</inclusion_criteria>
      <agemin>2 days</agemin>
      <agemax>28 days</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Cleft palate and lip
Any prohibition for massage
All preterm infants with congenital abnormalities such as congenital heart disease, gastrointestinal tract abnormalities, hypoxic injury, respiratory failure, current or past history of necrotizing enterocolitis, suspected or confirmed sepsis
Recent abdominal surgery</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>P07.3</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Preterm [premature] newborn [other]</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: The masseur in the intervention group gives her baby abdominal massage for 15 minutes at a certain time (9:00 a.m. and 9:00 p.m.) on five consecutive days (as trained).</i_keyword>
      <i_keyword>Intervention group 2: The masseur gives her neonetals a field massage for 15 minutes at a certain time (9:00 am and 9:00 pm) on five consecutive days (as trained).Field massage is such that each massage will consist of 3 phases of 5 minutes and a total of 15 minutes, in the first and third phase, the baby will be placed on the stomach and the massage will be performed as follows: 1) from the top of the head to the neck and vice versa, 2) from the neck to the shoulders and vice versa, 3) from the upper back to the waist and vice versa, 4) from the shoulder to the hand and then in the reverse direction in both hands, 5) from the thigh to the ankle leg and then in the reverse direction on both legs. In each of the mentioned areas, 12 movements of 5 seconds will be performed. In the second phase, the baby will be in the vault position and the passive movements of flexion and extension of the arms and legs separately and both legs together will be performed in 5 stages of one minute, each stage will include 6 movements of 10 seconds. Takes</i_keyword>
      <i_keyword>Control group: Newborns in the control group will receive the routine NICU care.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Physiological indicators. Timepoint: Before the intervention, after the intervention. Method of measurement: Saadat Monitoring Machine.</prim_outcome>
      <prim_outcome>Weight gain. Timepoint: Before the intervention, after the intervention. Method of measurement: Seca scale made by Persia factory.</prim_outcome>
      <prim_outcome>Digestive function. Timepoint: Before the intervention, after the intervention. Method of measurement: Syringe.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>personal</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-02-27</approval_date>
        <contact_name>Ethics Committee of Kerman University of Medical Sciences</contact_name>
        <contact_address>Haft Bagh Alavi, Pardizeh, Kerman University of Medical Sciences Kerman Kerman Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
